Brewin Dolphin Podcast

Brewin Dolphin Podcast


Fighting, Fish and Pharma

August 07, 2014

This week, Ruairidh Finlayson stands in as host to discuss the potential impact of sanctions put in place by Russia. BP, with its stake in Rosneft is under close scrutiny at this moment in time. However, our Oil & Gas analyst Iain Armstrong believes any impact on BP will be minimal due to such a small proportion of cash flow coming from their Russian interests. James Hay gives us an update on GlaxoSmithKline following results last week. Watch out for the dreadful badger joke too.

 

 

 

 

The value of investments can fall and you may get back less than you invested. Past performance is not a guide to future performance. All information within this publication is for illustrative purposes only and is not intended as investment advice. No investment is suitable in all cases and you have any doubts as to an investment’s suitability then you should contact your financial adviser. The opinions expressed in this podcast are not necessarily the views held throughout Brewin Dolphin Ltd. We or a connected person may have positions in or options on the securities mentioned herein or may buy, sell or offer to make a purchase or sale of such security mentioned in this podcast. For further information, please refer to our conflicts policy which is available on our website: www.brewin.co.uk
Â